Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and …

J Wang, M Jiang, X Chen… - Journal of Leucocyte …, 2020 - academic.oup.com
Clinical evidence indicates that the fatal outcome observed with severe acute respiratory
syndrome-coronavirus-2 infection often results from alveolar injury that impedes airway …

Current pharmacological treatments for COVID‐19: What's next?

C Scavone, S Brusco, M Bertini… - British journal of …, 2020 - Wiley Online Library
Since December 2019 SARS‐Cov‐2 was found responsible for the disease COVID‐19,
which has spread worldwide. No specific therapies/vaccines are yet available for the …

Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to SARS-CoV-2

E Barberis, S Timo, E Amede, VV Vanella… - International journal of …, 2020 - mdpi.com
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread to
nearly every continent, registering over 1,250,000 deaths worldwide. The effects of SARS …

Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review

AV Hernandez, YM Roman, V Pasupuleti… - Annals of internal …, 2020 - acpjournals.org
An update is available for this article. Background: Hydroxychloroquine and chloroquine
have antiviral effects in vitro against severe acute respiratory syndrome coronavirus 2 …

[PDF][PDF] Statins and the COVID-19 main protease: in silico evidence on direct interaction

Ž Reiner, M Hatamipour, M Banach, M Pirro… - Archives of Medical …, 2020 - termedia.pl
Results The binding energies obtained from the docking of 6LU7 with native ligand
favipiravir, nelfinavir, lopinavir, simvastatin, rosuvastatin, pravastatin, pitavastatin, lovastatin …

The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries

YA Adebisi, ND Jimoh, IO Ogunkola… - Tropical medicine and …, 2021 - Springer
Antimicrobial resistance is a hidden threat lurking behind the COVID-19 pandemic which
has claimed thousands of lives prior to the emergence of the global outbreak. With a …

The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis

NA Wong, MH Saier Jr - International journal of molecular sciences, 2021 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic
strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus …

COVID-19 as an acute inflammatory disease

RH Manjili, M Zarei, M Habibi… - The journal of immunology, 2020 - journals.aai.org
Abstract The 2019 coronavirus disease (COVID-19) pandemic caused by the virus severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created an unprecedented …

Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months

H Li, Z Liu, J Ge - Journal of cellular and molecular medicine, 2020 - Wiley Online Library
A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late
December, 2019, and subsequently, a novel coronavirus with a positive stranded RNA was …

[HTML][HTML] Chloroquine and hydroxychloroquine for the prevention or treatment of COVID-19 in Africa: caution for inappropriate off-label use in healthcare settings

PM Abena, EH Decloedt, E Bottieau… - The American journal …, 2020 - ncbi.nlm.nih.gov
The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa,
where nearly all countries have reported laboratory-confirmed cases of novel coronavirus …